FDMT vs K · rev $37.0K vs P/E 23, $29.03B cap
4D Molecular Therapeutics Inc (FDMT) versus Kellanova (K) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Kellanova (K) is a packaged foods company listed on US.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
K does not have a complete income-statement cache yet.
FDMT currently screens at market cap $518.1M. K currently screens at market cap $29.03B and trailing P/E 22.8.
Not investment advice. Open the FDMT and K stock pages for the full models.
Not investment advice.